ArticleJMIR medical informatics2026
Bridging Population Patterns and Individual Prediction: Framework for Prospective Multimorbidity Study.
Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Age and diabetic complications in type 2 diabetes: the role of disease duration and stage-dependent effects.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multimorbidity has become a major global public health challenge. However, existing research primarily emphasizes the identification of disease patterns at the population level and lacks the capacity to provide predictive insights into individual future pattern membership. Bridging this gap is crucial for personalized prevention and management. Objective: This study aims to propose an innovative framework that integrates population-level multimorbidity pattern recognition with individual-level predictive modeling, thus advancing multimorbidity research from descriptive analysis to prospective multimorbidity pattern prediction. Methods: Using longitudinal health follow-up data, we first applied latent transition analysis (LTA) to identify temporally stable multimorbidity patterns. These patterns were subsequently transformed into predictive labels to construct a novel deep learning model, CLA-Net (Cross-Lag Attention Network). CLA-Net is designed to predict individual future multimorbidity patterns by leveraging the complementary strengths of Gated Recurrent Units (GRU) and transformer architectures. It introduces a bitemporal directed cross-attention mechanism to simultaneously capture temporal dependencies and complex feature interactions. We compared CLA-Net against several advanced baselines and conducted ablation studies to validate its architectural components. Results: In terms of pattern recognition, the LTA identified 5 clinically meaningful multimorbidity patterns: Cardiometabolic-Multisystem, Hypertension-Arthritis, Respiratory-Musculoskeletal, Metabolic Syndrome, and Gastritis-Arthritis. In terms of prediction, experimental results demonstrated that CLA-Net significantly outperformed all baseline models. CLA-Net achieved an accuracy of 0.8352 (SD 0.0048), a precision of 0.8326 (SD 0.0053), a recall of 0.8312 (SD 0.0056), and an F1-score of 0.8319 (SD 0.0051). Notably, it achieved an area under the curve of 0.9293, surpassing baseline models. Ablation studies confirmed the necessity of the dual-branch architecture and the directed cross-attention mechanism, as removing these components resulted in performance declines ranging from 0.93% to 2.50%. Conclusions: This study extends the scope of LTA beyond descriptive statistical modeling and establishes the scientific value of multimorbidity pattern prediction as an independent research task. By bridging population-level insights with individual-level prediction, the proposed framework provides a data-driven tool for the prospective prediction of future multimorbidity pattern membership conditional on survival, thereby supporting stratified disease management and care planning, rather than general risk stratification for acute or end-stage deterioration. This offers new methodological and practical value for precision medicine and public health policymaking.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.